Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia

By Pordzik Sandra   Petrovici Karin   Schmid Christoph   Kroell Tanja   Schweiger Cornelia   Köhne Claus-Henning   Schmetzer Helga  

Hematology, Vol. 16, Iss. 6, 2011-11 ,pp. : 341-350

Maney Publishing

Access to resources Recommend Favorite

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis - analysis of 141 cases

By Lickliter J.D.   Kratzke R.A.   Nguyen P.L.   Niehans G.A.   Miller J.S.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1519-1527

Elsevier

Access to resources Recommend Favorite

Correlation of Loss of CD4 T Cells with Plasma Levels of Both Soluble Form Fas (CD95) and Fas Ligand (FasL) in HIV-Infected Infants

By Hosaka N.   Oyaizu N.   Than S.   Pahwa S.  

Clinical Immunology, Vol. 95, Iss. 1, 2000-04 ,pp. : 20-25

Academic Press

Access to resources Recommend Favorite

Role of CD95/Fas and its ligand in the regulation of the growth of human CD34 ++ CD38 - fetal liver cells - implications for the regulation of apoptosis in neutrophils

By Barcena A.   Muench M.O.   Song K.S.   Ohkubo T.   Harrison M.R.  

Experimental Hematology, Vol. 27, Iss. 9, 1999-09 ,pp. : 1428-1439

Elsevier

Access to resources Recommend Favorite

A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics

By Alenzi F.Q.B.   Marley S.B.   Lewis J.L.   Chandrashekran A.   Warrens A.N.   Goldman J.M.   Gordon M.Y.  

Experimental Hematology, Vol. 30, Iss. 12, 2002-12 ,pp. : 1428-1435

Elsevier

Access to resources Recommend Favorite